Evidence map›Paper›PMID 22593682›Full record

ArticleTheScientificWorldJournal2012

Isolation of a new Mexican strain of Bacillus subtilis with antifungal and antibacterial activities.

M G L Basurto-Cadena, M Vázquez-Arista, J García-Jiménez, R Salcedo-Hernández, D K Bideshi, J E Barboza-Corona

Open access · goldAbstract read
In one paragraph

Article in TheScientificWorldJournal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. The Prospect of Hydrolytic Enzymes fromInternational journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Endophytic BacteriaBiology · 2021
    Article
  6. Evaluation ofBiotechnology reports (Amsterdam, Netherlands) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

M G L Basurto-CadenaDivisión de Ciencias de Vida, Departamento de Alimentos, Universidad de Guanajuato Campus Irapuato-Salamanca, 36500, Irapuato, GTO, Mexico. cadenag@ugto.mx
M Vázquez-Arista
J García-Jiménez
R Salcedo-Hernández
D K Bideshi
J E Barboza-Corona
Universidad de Guanajuato · MXCalifornia Baptist University · USUniversitat Politècnica de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although several strains of B. subtilis with antifungal activity have been isolated worldwide, to date there are no published reports regarding the isolation of a native B. subtilis strain from strawberry plants in Mexico. A native bacterium (Bacillus subtilis 21) demonstrated in vitro antagonistic activity against different plant pathogenic fungi. Under greenhouse conditions, it was shown that plants infected with Rhizoctonia solani and Fusarium verticillioides and treated with B. subtilis 21 produced augment in the number of leaves per plant and an increment in the length of healthy leaves in comparison with untreated plants. In addition, B. subtilis 21 showed activity against pathogenic bacteria. Secreted proteins by B. subtilis 21 were studied, detecting the presence of proteases and bacteriocin-like inhibitor substances that could be implicated in its antagonistic activity. Chitinases and zwittermicin production could not be detected. Then, B. subtilis 21 could potentially be used to control phytopathogenic fungi that infect strawberry plants.

Indexed as

AntibiosisBacillus subtilisBacteriaBacterial ProteinsBacteriocinsFragariaFungiFusariumGram-Negative BacteriaGram-Positive BacteriaMexicoPeptide HydrolasesPeptidesPlant DiseasesPlant LeavesPolymerase Chain ReactionBacterial ProteinsBacteriocinsPeptide HydrolasesPeptideszwittermicin A

Identifiers

PMID22593682
PMCPMC3349141
OpenAlexW2011324027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.